Vanguard Group Inc Bio Affinity Technologies, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BIAF
# of Institutions
18Shares Held
512KCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA119KShares$40,3540.0% of portfolio
-
Sheaff Brock Investment Advisors, LLC53.7KShares$18,2690.0% of portfolio
-
Captrust Financial Advisors Raleigh, NC27.9KShares$9,4800.0% of portfolio
-
Warberg Asset Management LLC Winnetka, IL22.5KShares$7,6500.05% of portfolio
-
Hrt Financial LP New York, NY18.8KShares$6,4050.0% of portfolio
About bioAffinity Technologies, Inc.
- Ticker BIAF
- Exchange
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 2,727,580
- Market Cap $927K
- Description
- bioAffinity Technologies, Inc., a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat cancer at the cellular level. The company was founded in 2014 and is b...